Cargando…
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions
Sarcomas are driven by diverse pathogenic mechanisms, including gene rearrangements in a subset of cases. Rare soft tissue sarcomas containing KMT2A fusions have recently been reported, characterized by a predilection for young adults, sclerosing epithelioid fibrosarcoma-like morphology, and an ofte...
Autores principales: | Massoth, Lucas R., Hung, Yin P., Nardi, Valentina, Nielsen, G. Petur, Hasserjian, Robert P., Louissaint, Abner, Fisch, Adam S., Deshpande, Vikram, Zukerberg, Lawrence R., Lennerz, Jochen K., Selig, Martin, Glomski, Krzysztof, Patel, Parth J., Williams, Kevin Jon, Sokol, Ethan S., Alexander, Brian M., Vergilio, Jo-Anne, Ross, Jeffrey S., Pavlick, Dean C., Chebib, Ivan, Williams, Erik A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581494/ https://www.ncbi.nlm.nih.gov/pubmed/32461620 http://dx.doi.org/10.1038/s41379-020-0582-4 |
Ejemplares similares
-
Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors
por: Dhar, Shilpa S., et al.
Publicado: (2021) -
KMT2A: Umbrella Gene for Multiple Diseases
por: Castiglioni, Silvia, et al.
Publicado: (2022) -
Adult-onset KMT2B-related dystonia
por: Monfrini, Edoardo, et al.
Publicado: (2022) -
The KMT2A recombinome of acute leukemias in 2023
por: Meyer, C., et al.
Publicado: (2023) -
KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling
por: Yu, Bo, et al.
Publicado: (2022)